Other OTC Pharmaceuticals - Vietnam

Vietnam

Highlights

In Vietnam, the revenue generated in the Other OTC Pharmaceuticals market amounted to US$269.60m in 2024.
It is projected that the market will experience an annual growth rate of 2.48% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in this market, reaching US$7.17bn in 2024.
In terms of per person revenues, in Vietnam generates US$2.71 in 2024, taking into account the total population figures.
The demand for Other OTC Pharmaceuticals in Vietnam is driven by the increasing awareness of self-medication and the availability of affordable healthcare options.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in Vietnam has been experiencing significant growth in recent years.

Customer preferences: One of the main reasons for this growth is the increasing demand for self-medication among the Vietnamese population. As people become more health-conscious and proactive in managing their own health, they are turning to over-the-counter (OTC) pharmaceuticals for minor ailments and common health issues. This trend is driven by the convenience and accessibility of OTC products, as well as the rising awareness of the benefits of self-care.

Trends in the market: Another trend driving the growth of the Other OTC Pharmaceuticals market in Vietnam is the expanding middle class. As disposable incomes rise, more people are able to afford healthcare products and are willing to spend on OTC medications for non-serious health conditions. This has led to an increase in the consumption of OTC pharmaceuticals, particularly for common ailments such as cough and cold, pain relief, and digestive problems.Furthermore, the growing influence of digital technology and e-commerce has also contributed to the growth of the market. Online platforms and mobile applications have made it easier for consumers to access and purchase OTC pharmaceuticals, providing them with a wide range of product options and the convenience of doorstep delivery. This has further fueled the demand for OTC medications in Vietnam.

Local special circumstances: Vietnam has a large and young population, with a significant portion residing in rural areas. This presents a unique challenge in terms of healthcare access and affordability. Many people in rural areas do not have easy access to healthcare facilities or pharmacies, making OTC pharmaceuticals an attractive and convenient option for self-medication. Additionally, the lower cost of OTC medications compared to prescription drugs makes them more affordable for a population with varying income levels.

Underlying macroeconomic factors: Vietnam's strong economic growth and improving living standards have played a crucial role in the development of the Other OTC Pharmaceuticals market. As the country's economy continues to expand, more people are able to afford healthcare products and are willing to spend on OTC medications. Furthermore, the government's efforts to improve healthcare infrastructure and expand access to healthcare services have also contributed to the growth of the market.In conclusion, the Other OTC Pharmaceuticals market in Vietnam is growing rapidly due to the increasing demand for self-medication, the expanding middle class, the influence of digital technology and e-commerce, as well as the unique circumstances of the Vietnamese population. These factors, along with the country's strong economic growth and improving healthcare infrastructure, are expected to continue driving the growth of the market in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.